Nanoparticle-Mediated Inhibition of Mitochondrial Glutaminolysis to Amplify Oxidative Stress for Combination Cancer Therapy
Lei Xu,Rui Xu,Phei Er Saw,Jun Wu,Si-Xue Cheng,Xiaoding Xu
DOI: https://doi.org/10.1021/acs.nanolett.1c02073
IF: 10.8
2021-09-02
Nano Letters
Abstract:Selective amplification of reactive oxygen species (ROS) generation in tumor cells has been recognized as an effective strategy for cancer therapy. However, an abnormal tumor metabolism, especially the mitochondrial glutaminolysis, could promote tumor cells to generate high levels of antioxidants (e.g., glutathione) to evade ROS-induced damage. Here, we developed a tumor-targeted nanoparticle (NP) platform for effective breast cancer therapy via combining inhibition of mitochondrial glutaminolysis and chemodynamic therapy (CDT). This NP platform is composed of bovine serum albumin (BSA), ferrocene, and purpurin. After surface decoration with a tumor-targeting aptamer and then intravenous administration, this NP platform could target tumor cells and release ferrocene to catalyze hydrogen peroxide (H2O2) into the hydroxyl radical (·OH) for CDT. More importantly, purpurin could inhibit mitochondrial glutaminolysis to concurrently prevent the nutrient supply for tumor cells and disrupt intracellular redox homeostasis for enhanced CDT, ultimately leading to the combinational inhibition of tumor growth.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.nanolett.1c02073.Details of materials, experimental procedures, XPS spectrum, NP stability, nucleolin expression on MCF-7 and MCF-10A cells, viabilty of MCF-10A cells, fluorescence image of the tumors and main organs, body weight of mice, histological section of the major organs, serum level (PDF)This article has not yet been cited by other publications.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology